Ky. Rev. Stat. Ann. § 217.5406
If an eligible patient dies while being treated with an investigational drug, biological product, or device, the patient's heirs are not liable for any outstanding debt related to the treatment or to a lack of insurance as a result of the treatment.
Effective: June 29, 2017
History: Created 2017 Ky. Acts ch. 65, sec. 6, effective June 29, 2017. Formerly codified as KRS 217.5411.